Pfizer strikes deals in generics, emerging markets

NEW YORK (Reuters) – Pfizer Inc has struck licensing agreements with two Indian-based companies, as the world’s largest drugmaker seeks new avenues of growth in generics and emerging markets.

Leave a Reply